Perbedaan Fore Kopi Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Fore Kopi Indonesia Tbk. diperdagangkan di Rp615 (kapitalisasi pasar 5,44 T, volume 24 jam 1,89 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Fore Kopi Indonesia Tbk. jauh lebih besar — sekitar 32,5× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Fore Kopi Indonesia Tbk. lebih aktif diperdagangkan (1,89 jt vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.
| FORE | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 5,44 T | 167,37 M |
Volume | 1,89 jt | 71 rb |
Lot | 18,9 rb | 710 |
Perputaran | 1,15 M | 17,51 jt |
Harga Rata-rata | 609,92 | 246,63 |
Nilai Transaksi | 1,15 M | 17,51 jt |
Harga Ekuilibrium Indikatif | 615 | 246 |
Volume Ekuilibrium Indikatif | 1,29 rb | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Selengkapnya di halaman FORE →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →